These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 2334455

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Insulin resistance-reducing effect of a new thiazolidinedione derivative, pioglitazone].
    Ikeda H, Sugiyama Y.
    Nihon Yakurigaku Zasshi; 2001 May; 117(5):335-42. PubMed ID: 11411343
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Actions of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells.
    Arakawa K, Ishihara T, Aoto M, Inamasu M, Saito A, Ikezawa K.
    Br J Pharmacol; 1998 Oct; 125(3):429-36. PubMed ID: 9806323
    [Abstract] [Full Text] [Related]

  • 26. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
    Hofmann CA, Edwards CW, Hillman RM, Colca JR.
    Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pioglitazone: beyond glucose control.
    de Pablos-Velasco P.
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1057-67. PubMed ID: 20670183
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase.
    Kobayashi M, Iwanishi M, Egawa K, Shigeta Y.
    Diabetes; 1992 Apr; 41(4):476-83. PubMed ID: 1318856
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.
    Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN, Meglasson MD.
    Diabetes; 1994 Feb; 43(2):204-11. PubMed ID: 8288044
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats.
    Vikram A, Jena G.
    Biochem Biophys Res Commun; 2010 Jul 23; 398(2):260-5. PubMed ID: 20599729
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells.
    Solomon SS, Mishra SK, Cwik C, Rajanna B, Postlethwaite AE.
    Horm Metab Res; 1997 Aug 23; 29(8):379-82. PubMed ID: 9288574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.